3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Unknown
2
Completed
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
2
Conditions
Carcinoma, Non-Small-Cell Lung
44
Colorectal Neoplasms
22
Breast Neoplasms
22
Stomach Neoplasms
21
Neoplasms
18
Esophageal Squamous Cell Carcinoma
12
Neoplasm Metastasis
11
Nasopharyngeal Carcinoma
11
Lung Neoplasms
11
Rectal Neoplasms
9
Colonic Neoplasms
8
Pancreatic Neoplasms
7
Uterine Cervical Neoplasms
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Ovarian Neoplasms
5
Osteosarcoma
5
Brain Neoplasms
5
Small Cell Lung Carcinoma
4
Recurrence
4
Glioblastoma
4
Gastrointestinal Neoplasms
4
Precision Cell Immunotherapy
3
Melanoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Head and Neck Neoplasms
3
Gastrointestinal Diseases
3
Digestive System Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Interventions
pegaspargase
14
Etoposide
11
Dexamethasone
11
Gemcitabine
10
spartalizumab
6
Oxaliplatin
4
sintilimab
3
Radiotherapy
3
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
3
Methotrexate
3
Asparaginase
3
tislelizumab
2
camrelizumab
2
Lenalidomide
2
Drug Therapy
2
Cyclophosphamide
2
Cisplatin
2
Busulfan
2
Azacitidine
2
toripalimab
1
tofacitinib
1
ruxolitinib
1
romidepsin
1
pembrolizumab
1
fludarabine phosphate
1
avelumab
1
apatinib
1
Thalidomide
1
Sensitivity and Specificity
1
Psychiatric Rehabilitation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, Extranodal NK-T-Cell
×
Drug Therapy
×
Clear all
NCT01501136
2015-07-17
CTTNKTL-I/II
Zhengzhou University
Phase 4
Unknown
200 enrolled
NCT00725231
2012-05-07
A-CHOP-14
University of Göttingen
Phase 3
Unknown
274 enrolled